Horizon Pharma weighs sale of primary care unit -sources

Sept 15 (Reuters) - Specialty drugmaker Horizon Pharma PLC is working with investment bank Morgan Stanley to review strategic options for its primary care drugs business, including a potential sale of the unit, people familiar with the matter said on Friday.